Your browser doesn't support javascript.
loading
Cotadutide promotes glycogenolysis in people with overweight or obesity diagnosed with type 2 diabetes.
Parker, Victoria E R; Robertson, Darren; Erazo-Tapia, Edmundo; Havekes, Bas; Phielix, Esther; de Ligt, Marlies; Roumans, Kay H M; Mevenkamp, Julian; Sjoberg, Folke; Schrauwen-Hinderling, Vera B; Johansson, Edvin; Chang, Yi-Ting; Esterline, Russell; Smith, Kenneth; Wilkinson, Daniel J; Hansen, Lars; Johansson, Lars; Ambery, Philip; Jermutus, Lutz; Schrauwen, Patrick.
Afiliação
  • Parker VER; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK. victoria.parker@astrazeneca.com.
  • Robertson D; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
  • Erazo-Tapia E; Department of Nutrition and Movement Sciences, NUTRIM School for Nutrition and Translational Research in Metabolism, Maastricht University Medical Centre, Maastricht, the Netherlands.
  • Havekes B; Department of Nutrition and Movement Sciences, NUTRIM School for Nutrition and Translational Research in Metabolism, Maastricht University Medical Centre, Maastricht, the Netherlands.
  • Phielix E; Division of Endocrinology and Metabolism, Department of Internal Medicine, Maastricht University Medical Center, Maastricht, the Netherlands.
  • de Ligt M; Department of Nutrition and Movement Sciences, NUTRIM School for Nutrition and Translational Research in Metabolism, Maastricht University Medical Centre, Maastricht, the Netherlands.
  • Roumans KHM; Department of Nutrition and Movement Sciences, NUTRIM School for Nutrition and Translational Research in Metabolism, Maastricht University Medical Centre, Maastricht, the Netherlands.
  • Mevenkamp J; Department of Nutrition and Movement Sciences, NUTRIM School for Nutrition and Translational Research in Metabolism, Maastricht University Medical Centre, Maastricht, the Netherlands.
  • Sjoberg F; Department of Nutrition and Movement Sciences, NUTRIM School for Nutrition and Translational Research in Metabolism, Maastricht University Medical Centre, Maastricht, the Netherlands.
  • Schrauwen-Hinderling VB; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center, Maastricht, the Netherlands.
  • Johansson E; Clinical Trial Consultants AB, Uppsala, Sweden.
  • Chang YT; Linköping University, Linköping, Sweden.
  • Esterline R; Department of Nutrition and Movement Sciences, NUTRIM School for Nutrition and Translational Research in Metabolism, Maastricht University Medical Centre, Maastricht, the Netherlands.
  • Smith K; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center, Maastricht, the Netherlands.
  • Wilkinson DJ; Antaros Medical AB, Mölndal, Sweden.
  • Hansen L; Early Clinical Development, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Johansson L; Late-stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Ambery P; Centre of Metabolism, Ageing and Physiology, Royal Derby Hospital Centre, School of Medicine, University of Nottingham, Derby, UK.
  • Jermutus L; Centre of Metabolism, Ageing and Physiology, Royal Derby Hospital Centre, School of Medicine, University of Nottingham, Derby, UK.
  • Schrauwen P; Late-stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Nat Metab ; 5(12): 2086-2093, 2023 Dec.
Article em En | MEDLINE | ID: mdl-38066113

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Glicogenólise / Hepatopatia Gordurosa não Alcoólica Limite: Female / Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Glicogenólise / Hepatopatia Gordurosa não Alcoólica Limite: Female / Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article